In vitro as well as in vivo studies in xenograft mouse models suggested that CD4+ T cells could enhance the survival and proliferation of clonal cells in CLL, a finding that was supported by correlations between CD4+ T cell counts and clinical outcome (79, 80). Here, CD4 is linked to B-cell chronic lymphocytic leukemia.